Buscar
01/06/2025
Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome
Sauer, M, Gomes, BF, Shahrouki, P, Lantero-Rodriguez, J, Montoliu-Gaya, L, Camporesi, E, Belbin, O, Alcolea, D, Kumar, A, Sharma, M, Singh, S, Brinkmalm, G, Gobom, J, Carmona-Iragui, M, Schöll, M, Janelidze, S, Deep, G, Blennow, K, Zetterberg, H, Brinkmalm, A, Lleó, A, Fortea, J, Hansson, O, Ashton, NJ, Nilsson, J. Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70241. PMID:40522075. IF:11.100(Q1/1D).
01/06/2025
Bridging perspectives: The value of collaboration between Traditional Healing Practitioners and Medical Doctors in dementia research and care in South Africa
McGlinchey, E, Ranchod, K, Stroebel, R, Lusizi, B, Galvin, M, Kleinhans, AV, Fortea, J, Hoffman, J, Makanya, S. Bridging perspectives: The value of collaboration between Traditional Healing Practitioners and Medical Doctors in dementia research and care in South Africa. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70370. PMID:40566835. IF:11.100(Q1/1D).
01/06/2025
Adverse drug events associated with emergency departments visits
Ramos, JR, Perrín, RS, Martín, MAG, Clemente, YC, Díez, MA, Pinto, AD, Díaz, AS, Almela, AFD, Serrano, PS, Grande, ASL, Blanco, CC. Adverse drug events associated with emergency departments visits. EMERGENCIAS. 2025; 37(3)DOI:10.55633/s3me/025.2025. PMID:. IF:6.300(Q1/1D).
01/06/2025
Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview
Delaby, C, Ladang, A, Martinez-Yriarte, J, Zecca, C, Logroscino, G, Koertvelyessy, P, Tumani, H, Parchi, P, Quadrio, I, Hart, M, Olsen, DA, Alcolea, D, Blennow, K, Fortea, J, Lleo, A, Algeciras-Schimnich, A, Ayrignac, X, Bedel, A, Santos, GAA, Borelli, W, Bouaziz-Amar, E, Baldeiras, I, Bigot-Corbel, E, Bjerke, M, Perez, MC, Casoli, T, Chabrashvili, T, Chapman, MD, Cusato, J, Dursun, E, Fourier, A, Galimberti, D, Gezen-Ak, D, Gordon, BA, Gouju, J, Florez, SD, Sanchez, JH, Herwerth, M, Imperiale, D, Kaczorowski, F, Kasuga, K, Keshavan, A, Khalil, M, Kuhle, J, Leithner, C, Lewczuk, P, Letournel, F, Tsolaki, M, Giuffre, GM, Blanc, MC, Mroczko, B, Rodriguez, JEM, Musso, G, Kulczynska-Przybik, A, Nogueira, L, Paquet, C, Baiardi, S, Gaetani, L, Parnetti, L, Garay, RP, Poesen, K, Quillard-Muraine, M, Borja, ER, Schraen, S, Terracciano, D, Bachhuber, F, Halbgebauer, S, Tzartos, S, Tzartos, J, Unterwalder, N, Vermunt, L, Wellington, CL, Zetterberg, H, Teunissen, C, Lehmann, S. Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70343. PMID:40551293. IF:11.100(Q1/1D).
01/06/2025
Clinical-epidemiological aspects, hospitalization, and reconsultations in older patients with atrial fibrillation in emergency departments in Spain (EDEN-35 study): sex-disaggregated analysis
Coll-Vinent, B, Hernández, NM, Marco, NC, Boixeda, C, Rodríguez, JJ, Alquézar-Arbé, A, Alonso, CF, Burillo-Putze, G, Montero-Pérez, FJ, del Castillo, JG, Miró, O. Clinical-epidemiological aspects, hospitalization, and reconsultations in older patients with atrial fibrillation in emergency departments in Spain (EDEN-35 study): sex-disaggregated analysis. EMERGENCIAS. 2025; 37(3)DOI:10.55633/s3me/035.2025. PMID:40531120. IF:6.300(Q1/1D).
01/06/2025
Discrepancies in assessing intellectual disability levels in adults with Down syndrome: Implications for dementia diagnosis
Soriano, LD, Sandkühler, K, Videla, L, Benejam, B, Carmona-Iragui, M, Wlasich, E, Kustermann, J, Barroeta, I, Vaqué-Alcázar, L, Rodríguez-Baz, I, Bejanin, A, Fernández, S, Arranz, J, Arriola-Infante, JE, Maure-Blesa, L, Juan, AS, Nübling, G, Wagemann, O, Stockbauer, A, Hassenstab, J, Levin, J, Fortea, J. Discrepancies in assessing intellectual disability levels in adults with Down syndrome: Implications for dementia diagnosis. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70307. PMID:40528393. IF:11.100(Q1/1D).
01/06/2025
Down syndrome in Africa: Challenges, opportunities, and future directions
McGlinchey, E, Tewolde, S, He, AMD, Fortea, J, Mbakile-Mahlanza, L, Tefera, A, Epenge, E, Hassenstab, J, Jaeck, A, Ranchod, K, El-Jaafary, S, Levin, J, Salama, M, Rubenstein, E, Akinyemi, R, Akinyemi, T, Farombi, T, Lawlor, B, Ikanga, J, Ashton, NJ, Stout, S, Balls-Berry, J, Kleinhans, AV, Maina, R, Merali, Z. Down syndrome in Africa: Challenges, opportunities, and future directions. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70388. PMID:40538002. IF:11.100(Q1/1D).
01/06/2025
The history of Down syndrome-associated Alzheimer's disease; past, present, and future
Maure-Blesa, L, Carmona-Iragui, M, Lott, I, Head, E, Wisniewski, T, Rafii, MS, Espinosa, J, Flórez, J, Mobley, WC, Holland, A, Strydom, A, Zaman, S, Fortea, J. The history of Down syndrome-associated Alzheimer's disease; past, present, and future. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70158. PMID:40469048. IF:11.100(Q1/1D).